Blueprint Medicines Corp Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Blueprint Medicines Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q3 2024.
  • Blueprint Medicines Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$7.03M, a 55% decline year-over-year.
  • Blueprint Medicines Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $149M.
  • Blueprint Medicines Corp annual Nonoperating Income (Expense) for 2023 was -$19.7M, a 33.7% decline from 2022.
  • Blueprint Medicines Corp annual Nonoperating Income (Expense) for 2022 was -$14.8M, a 1746% decline from 2021.
  • Blueprint Medicines Corp annual Nonoperating Income (Expense) for 2021 was $897K, a 85.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $149M -$7.03M -$2.49M -55% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $151M -$6.85M -$2.23M -48.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $153M $168M +$173M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$19.7M -$5.75M +$2.06M +26.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 -$21.8M -$4.54M +$3.46M +43.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 -$25.3M -$4.62M -$5.68M -536% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$19.6M -$4.83M -$4.82M -43836% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$14.8M -$7.81M -$7.89M -9511% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 -$6.87M -$8M -$8.03M -26767% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $1.16M $1.06M +$799K +307% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $362K -$11K -$535K -102% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $897K $83K -$903K -91.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $1.8M $30K -$951K -96.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $2.75M $260K -$1.3M -83.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $4.05M $524K -$2.18M -80.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $6.23M $986K -$2.06M -67.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $8.29M $981K -$2.71M -73.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $11M $1.56M -$2.67M -63.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $13.7M $2.7M +$37K +1.39% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $13.6M $3.05M +$227K +8.05% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-13
Q3 2019 $13.4M $3.69M +$901K +32.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $12.5M $4.23M +$1.81M +75% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $10.7M $2.67M +$304K +12.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $10.4M $2.82M +$1.75M +165% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-13
Q3 2018 $8.63M $2.79M +$1.88M +207% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-13
Q2 2018 $6.75M $2.42M +$1.62M +202% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-13
Q1 2018 $5.14M $2.36M +$2.01M +569% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-13
Q4 2017 $3.13M $1.07M +$956K +869% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 $2.17M $907K +$858K +1751% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 $1.31M $802K +$800K Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 $514K $353K +$432K Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 $82K $110K +$264K Oct 1, 2016 Dec 31, 2016 10-K 2018-02-21
Q3 2016 -$182K $49K +$214K Jul 1, 2016 Sep 30, 2016 10-K 2018-02-21
Q2 2016 -$396K $2K* +$586K Apr 1, 2016 Jun 30, 2016 10-K 2018-02-21
Q1 2016 -$982K -$79K +$143K +64.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-21
Q4 2015 -$1.13M -$154K +$21K +12% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 -$1.15M -$165K +$49K +22.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-09
Q2 2015 -$1.2M -$584K -$496K -564% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-09
Q1 2015 -$699K -$222K -$148K -200% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-09
Q4 2014 -$551K -$175K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$214K Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$88K Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$74K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.